|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Lipitor case study: Lifecycle management strategies |
|
|
|
|
€ 250,75 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Novembre 2005 |
Taille du document : |
13 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (4) |
|
|
|
| 21 pages | Janvier 2003 | Anglais
|
|
|
| Main
focus: |
statins,cardiovascular diseases,cancer
|
| Research
focus: |
market outlook,industry structure |
| Geographic
focus: |
china,pakistan,india,indonesia,malaysia,uruguay,... |
| |
|
|
|
|
| 25 pages | Janvier 2007 | Anglais
|
|
|
| Main
focus: |
savings
|
| Research
focus: |
demand analysis,industry structure, |
| Geographic
focus: |
united kingdom,france |
| |
|
|
|
|
| 23 pages | Mai 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,statins
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
france,united kingdom,denmark,norway,italy,... |
| |
|
|
|
|
| 26 pages | Décembre 2005 | Anglais
|
|
|
| Main
focus: |
savings,hospital,hospitals
|
| Research
focus: |
market definition,market outlook,pricing policy, |
| Geographic
focus: |
france,united kingdom,usa,croatia |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The UK piling Market
40 pages | Mai 2002 |
This report will enable you to:Analyse the size of the UK market for piling between 1997 and 2006Quantify the size of the UK market for piling, 1997-2006, by technique: - bored - driven - embedded |
365,00 €
|
| |
| |
Healthcare In Southern Ireland
40 pages | Mai 2000 |
The Republic Of Ireland Presentation Includes:- The Structure Of The Health Service In The Republic Of Ireland- Capital Expenditure On Health Care In The Republic Of Ireland- Number Of Publicly Funded |
327,00 €
|
| |
| |
The Pharmaceutical Distribution Outlook 1998-2008
165 pages | Octobre 1998 |
Industry growth and consolidation means that pharmaceutical manufacturers are no longer geographically limited in their operations and now market their products globally, creating a vast commercia |
795,00 €
|
| |
| |
The Pharmacogenomics Outlook
174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development.
By identifying differenc |
955,00 €
|
| |
| |
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
240 pages | Juin 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once a company's freedom over pricing decisions was almost limitless, external pressure |
955,00 €
|
| |
| |
Healthcare In Wales
50 pages | Mai 2000 |
The Welsh Presentation Includes:- The Structure Of The NHS In Wales- Revenue Expenditure On Health Services In Wales- Number Of Hospital Units - Number Of Available Inpatient Beds- Number Of Occupied |
327,00 €
|
| |
| |
Healthcare: Germany
106 pages | Octobre 2000 |
Compare the changes in expenditure between the different healthcare sectors in Germany · Understand the main factors affecting demand for healthcare services in Germany · Examine the |
578,54 €
|
| |
| |
The CNS Outlook 2000
203 pages | Octobre 2000 |
The Central Nervous System (CNS) market has shown sustained growth in 1999 with the expansion continuing to be driven by several factors.A greater understanding of the neuropharmacological mechanisms |
955,00 €
|
| |
| |
Pharmaceutical Pricing Strategies
121 pages | Juillet 1998 |
Which pricing strategies will enable your company to maximise profitability? As healthcare cost-containment intensifies and pricing freedom is eroded, the need to develop new strategies to mainta |
795,00 €
|
| |
| |
The Japanese Pharmaceutical Market Outlook 2001
142 pages | Août 2001 |
Although Japan is the second largest pharmaceutical market in the world, it has traditionally been a relative 'no-go' area for pre-eminent Western drug companies.
Now, however, extensive cultur |
1 200,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Lipitor case study: Lifecycle management strategies |
|
|
Since its launch, Lipitor has become the leading cholesterol-lowering drug in the US and the most widely prescribed drug in the world. However, numerous generic based statins and statin-based combination therapies are being developed which could threaten its market position. Pfizer is therefore developing a combination therapy - combining Lipitor with its CETP inhibitor, torcetrapib - to combat this threat.
|
|
Since its launch, Lipitor has become the leading cholesterol-lowering drug in the US and the most widely prescribed drug in the world. However, numerous generic based statins and statin-based combination therapies are being developed which could threaten its market position. Pfizer is therefore developing a combination therapy - combining Lipitor with its CETP inhibitor, torcetrapib - to combat this threat.
|
|
|
PPLSEN
|
|
|
|
|
